Chief China life sciences advisor Katherine Wang authored an article in the May/June issue of Pharma magazine. In the article, she explores the regulatory framework governing pharmaceuticals in China, discusses regulatory development trends and analyzes the potential impact on foreign pharmaceutical manufacturers.
